ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 261

Ultrasound CUT-Off in GIANT CELL Arteritis a Solution to Arteriosclerosis Pitfall in the Halo Sign

Eugenio De Miguel1, Luis M Beltran2, Irene Monjo2, Francesco Deodati2, Wolfgang A. Schmidt3 and Juan García-Puig2, 1Rheumatology, University Hospital La Paz, IdiPaz, Madrid, Spain, 2Internal Medicine, Hospital Universitario La Paz, MADRID, Spain, 3Immanuel Krankenhaus Berlin, Med Ctr for Rheumatology Berlin-Buch, Berlin, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: diagnosis, Diagnostic imaging, giant cell arteritis, ultrasound and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: At the age of Giant Cell Arteritis (GCA) atherosclerosis is common. The ultrasonographic (US) appearance of athermanous plaque is usually easily differentiated from the hypoechoic halo of GCA. However, the US increase of the intima-media-thickness (IMT) in an atherosclerotic arteries may have a similar appearance as the halo sign (homogenous, hypoechoic wall thickening, well delineated towards the luminal side, visible in longitudinal and transverse planes). The new US high frequencies probes make possible not only to see the halo sign but also measure the increase of the intima-media-thickness (IMT), in this sense the aim of this study was to explore the better cut-off in the IMT of temporal arteries (TA) to minimise the number of false-positive GCA diagnosis caused by atherosclerosis.

Methods: Consecutive non selected patients, ≥50 years-old with high vascular risk according to European Guidelines on cardiovascular disease prevention, and without signs or symptoms of GCA, were included.

Ultrasonography of carotid artery: Carotid US examinations were performed on a Mylab Seven (Esaote Medical Systems, Italy) with a 4–13 MHz linear-array. The system employed dedicated software radiofrequency-tracking technology to obtain IMT (QIMT®).

Ultrasonography of temporal superficial artery: A color Doppler ultrasound (CDU) and grey scale measure of the IMT/halo sign in both TA and its branches was performed by a second experienced sonographer. A Mylab Twice equipment (Esaote, Geneve, Italy) was used, with a 22 MHz frequency for grey scale and a 12.5 MHz for CDU (color gain of 51, PRF of 2 kHz). The sonographer was blind to the clinical and carotid ultrasound IMT data.

Results: Forty patients were studied, 28 men (70%), with a mean age of 70.6 ± 6.9 years. Three patients were active smokers and 27 ex-smokers. Arterial hypertension was present in 39 (97.5%), dyslipidaemia in 34 (85%) and diabetes in 19 (47.5%). The mean erythrocyte sedimentation rate was 13.6 ± 11.0. Eighty carotids were studied, 50 had plaques and 30 did not with a IMT ranged from 0.528 to 1.480 mm. A increase in the carotid IMT is associated with an increase in the IMT of the TA with a weak Spearman correlation (parietal branches 0.282 p = 0.012 and frontal branches 0.228 p = 0.048). The table shows that an IMT > 0.30 mm (halo sign) was seen in at least 1 TA branch of 18 patients (45%) with 33 TA branches affected (20.6%). An IMT cut-off > 0.34 mm, was present in 4 patients (10 %). When at least two affected branches with this measure were required to make the US diagnosis (criteria recommended to improve specificity) only one patient (2.5%) produced a false-positive halo sign.

Tabla.jpg

Conclusion: Carotid atherosclerosis increase the IMT in TA and is a potential cause of false-positive halo sign. We propose a cut-off of AT IMT > 0.34 mm in at least two branches to minimise the number of false positives in GCA diagnosis.


Disclosure: E. De Miguel, None; L. M. Beltran, None; I. Monjo, None; F. Deodati, None; W. A. Schmidt, Roche Pharmaceuticals, 8,Roche Pharmaceuticals, 5,Roche Pharmaceuticals, 2,GlaxoSmithKline, 2,GlaxoSmithKline, 5,Bristol-Myers Squibb, 5,Bristol-Myers Squibb, 8; J. García-Puig, None.

To cite this abstract in AMA style:

De Miguel E, Beltran LM, Monjo I, Deodati F, Schmidt WA, García-Puig J. Ultrasound CUT-Off in GIANT CELL Arteritis a Solution to Arteriosclerosis Pitfall in the Halo Sign [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/ultrasound-cut-off-in-giant-cell-arteritis-a-solution-to-arteriosclerosis-pitfall-in-the-halo-sign/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-cut-off-in-giant-cell-arteritis-a-solution-to-arteriosclerosis-pitfall-in-the-halo-sign/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology